Myovant Sciences Ltd. (21)

Browse by Contract Category

Contracts

Form of Restricted Stock Unit Grant Notice and (Filed With SEC on November 12, 2020)
Form of Option Grant Notice and Option Agreement under 2020 Inducement Plan (Filed With SEC on November 12, 2020)
Commercial Manufacturing and Supply Agreement, dated April 4, 2019, by and between Excella GmbH & Co. KG and Myovant Sciences GmbH (Filed With SEC on November 12, 2020)
Consulting Agreement, dated May 18, 2020, by and between the Registrant and Sumitovant BioPharma Ltd (Filed With SEC on August 11, 2020)
2020 Inducement Plan (Filed With SEC on November 12, 2020)
Commitment Letter Amendment Letter (Filed With SEC on November 12, 2020)
Commitment Letter, dated August 5, 2020, by and between Sumitomo Dainippon Pharma Co., Ltd. and the Registrant (Filed With SEC on November 12, 2020)
Market Access Services Agreement, dated as of August 1, 2020, by and between Sunovion Pharmaceuticals Inc. and Myovant Sciences GmbH (Filed With SEC on November 12, 2020)
Description of Common Shares (Filed With SEC on May 18, 2020)
Investor Rights Agreement, dated as of December 27, 2019, by and among the Registrant, Sumitovant Biopharma Ltd. and Sumitomo Dainippon Pharma Co., Ltd (Filed With SEC on February 10, 2020)
Loan Agreement, dated as of December 27, 2019, by and among Sumitomo Dainippon Pharma Co., Ltd., as the Lender, the Registrant, as the Parent, and Myovant Sciences GmbH, as the... (Filed With SEC on February 10, 2020)
Letter Agreement, dated October 31, 2019, by and between the Registrant and Sumitomo Dainippon Pharma Co., Ltd (Filed With SEC on February 10, 2020)
Form of Restricted Stock Unit Grant Notice and Award Agreement under 2016 Equity Incentive Plan, as amended (2019 Form) (Filed With SEC on November 12, 2019)
Form of Amendment No.1 to the Stock Option Grant Notice and Option Agreement under 2016 Equity Incentive Plan, as amended (Filed With SEC on November 12, 2019)
Underwriting Agreement, by and between Myovant Sciences Ltd. and J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC, Cowen and Company, LLC, and Evercore Group L.L.C., as... (Filed With SEC on May 31, 2019)
Amendment No.1 to Information Sharing and Cooperation Agreement, dated as of May 24, 2019, by and between Roivant Sciences Ltd. and the Registrant (Filed With SEC on May 24, 2019)
Non-Employee Director Compensation Policy (Filed With SEC on May 24, 2019)
Form of Restricted Stock Award Agreement under 2016 Equity Incentive Plan, as amended (Filed With SEC on May 24, 2019)
Form of Restricted Stock Unit Grant Notice and Award Agreement under 2016 Equity Incentive Plan, as amended (Filed With SEC on May 24, 2019)
Restricted Stock Award Agreement, dated May 31, 2017, by and between Myovant Sciences Ltd. and Lynn Seely (Filed With SEC on May 24, 2019)
Employment Agreement, dated as of November 1, 2018, by and between Kim Sablich and Myovant Sciences, Inc (Filed With SEC on February 7, 2019)